Dose-Escalated G-CSF Dose Not Improve Resolution of Neutropenia Compared to Standard-Dose G-CSF Following Autologous Stem Cell Transplantation

被引：0
|
作者：
Trifilio, Steven [1 ]
Fong, Jessica I. [1 ]
Zhao, Cindy [1 ]
Zhang, Junyu [1 ]
Liu, Derek [1 ]
Villa, Marcelo [2 ]
Mehta, Jayesh [3 ]
机构：
[1] NW Mem Hosp, Chicago, IL 60611 USA
[2] NW Mem Hosp, Cell Therapy Proc Facil, Chicago, IL 60611 USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2014.11.157
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
127
引用
收藏
页码：S122 / S123
页数：2
相关论文
共 50 条
  • [41] Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation
    Colby, C
    McAfee, SL
    Finkelstein, DM
    Spitzer, TR
    BONE MARROW TRANSPLANTATION, 1998, 21 (10) : 1005 - 1010
  • [42] G-CSF instead of autologous stem cell transplantation after high dose melphalan as front-line therapy in multiple myeloma.
    Harousseau, JL
    Facon, T
    Maloisel, F
    DabouzHarrouche, F
    Witz, F
    Guilhot, F
    Archimbaud, E
    Desablens, B
    Abgrall, JF
    Linassier, C
    Grosbois, B
    Bancillon, A
    Badri, N
    Bataille, R
    BLOOD, 1995, 86 (10) : 725 - 725
  • [43] ANALYSIS OF AUTOLOGOUS RECOVERY AND TRANSFUSIONAL REQUIREMENTS IN MOBILIZED TRANSPLANTATION WITH G-CSF plus PLERIXAFOR VERSUS G-CSF
    Raposo Puglia, J. A.
    Verdugo Cabeza de Vaca, M. V.
    Salamanca Cuenca, A.
    Correa Alonso, M. A.
    Ordonez Vahi, S.
    HAEMATOLOGICA, 2017, 102 : 112 - 113
  • [44] High dose cyclophosphamide plus GM-CSF versus G-CSF alone to mobilize PBSCs for autologous transplantation in multiple myeloma
    Alegre, A
    Tomas, LF
    Escudero, A
    GilFernandez, JL
    Arranz, R
    Granda, A
    LopezPascual, K
    Lopez, JL
    Pinilla, I
    FernandezRanada, JM
    BLOOD, 1995, 86 (10) : 3733 - 3733
  • [45] Efficacy of a fixed low dose G-CSF in reconstitution of hematopoiesis after double autologous blood stem cell transplantation in solid tumors.
    Sayer, HG
    Kath, R
    Vogt, T
    Hoffmann, K
    Hartmann, M
    Höffken, K
    BLOOD, 2000, 96 (11) : 298A - 298A
  • [46] Role of G-CSF after High-Dose Post-Transplantation Cyclophospamide
    Elayan, Mohammed M.
    Li, Belinda K.
    Battiwalla, Minoo
    Bachier, Carlos R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S143 - S144
  • [47] Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation
    C Colby
    SL McAfee
    DM Finkelstein
    TR Spitzer
    Bone Marrow Transplantation, 1998, 21 : 1005 - 1010
  • [48] Role of G-CSF after High-Dose Post-Transplantation Cyclophospamide
    Elayan, Mohammed M.
    Bachier, Carlos R.
    Battiwalla, Minoo
    Siler, Darby
    BLOOD, 2018, 132
  • [49] Intermediate dose of G-CSF and mobilization on blood stem cells in 7 healthy donors
    Bonfichi, M
    Balduini, A
    Alessandrino, EP
    Pagnucco, G
    Bernasconi, P
    Castagnola, C
    Marseglia, C
    Brera, C
    Vanelli, L
    Bernasconi, C
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 307 - 307
  • [50] Superior autologous blood stem cell mobilization (BSCM) with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) plus G-CSF than with less intensive chemotherapy (CT) plus G-CSF
    Stewart, DA
    Guo, D
    Brown, C
    Poon, MC
    Ruether, B
    Jones, A
    Klassen, J
    Luider, J
    Morris, D
    Chaudhry, A
    Russell, JA
    BLOOD, 1997, 90 (10) : 433 - 433
12345